UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]

International journal of chronic obstructive pulmonary disease, 2021-05, Vol.16, p.1347-1348

2021

Volltextzugriff (PDF)

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]

International journal of chronic obstructive pulmonary disease, 2020-05, Vol.15, p.1177-1178

2020

Volltextzugriff (PDF)

Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.1061-1073

2021

Volltextzugriff (PDF)

P813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB

HemaSphere, 2022-06, Vol.6 (Suppl), p.707-708

2022

Volltextzugriff (PDF)

Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.945-955

2021

Volltextzugriff (PDF)

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.995-1004

2020

Volltextzugriff (PDF)

Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.865-875

2021

Volltextzugriff (PDF)

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.745-754

2020

Volltextzugriff (PDF)

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.461-470

2019

Volltextzugriff (PDF)

Environmental aspects of the carcinogenic situation in developed industrial region

Kazanskij medicinskij z̆urnal, 2022-02, Vol.81 (4), p.333-335

2022

Volltextzugriff (PDF)

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other

Advances in experimental medicine and biology, 2008, Vol.622, p.15

2008

Volltextzugriff (PDF)

Role of p53 and Rb in ovarian cancer

Advances in experimental medicine and biology, 2008, Vol.622, p.99

2008

Volltextzugriff (PDF)

CORRIGENDUM

International journal of chronic obstructive pulmonary disease, 2021-05, Vol.16, p.1347

2021

Volltextzugriff (PDF)

Ovarian carcinogenesis: an alternative hypothesis

Advances in experimental medicine and biology, 2008, Vol.622, p.79

2008

Volltextzugriff (PDF)

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Patient Device Satisfaction With Eflow Closed System Nebulizer: Results From The Golden-5 Study In Patients With Moderate-To Very-Severe Chronic Obstructive Pulmonary Disease (COPD)

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Health-Related Quality Of Life (hrqol) In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Sun-101 (glycopyrrolate/eflow®): Findings From The Phase 3 Golden Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C49 COPD: TREATMENT: Improvement In Respiratory Symptoms In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease Patients Treated With Sun-101 (glycopyrrolate/eflow®) - Patient-Reported Outcomes From The Phase 3 Golden Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Regulatory T cells: a new frontier in cancer immunotherapy

Advances in experimental medicine and biology, 2008, Vol.622, p.255

2008

Volltextzugriff (PDF)

Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax

Advances in experimental medicine and biology, 2008, Vol.622, p.169

2008

Volltextzugriff (PDF)

Potential and limitations in early diagnosis of ovarian cancer

Advances in experimental medicine and biology, 2008, Vol.622, p.3

2008

Volltextzugriff (PDF)

Defective apoptosis underlies chemoresistance in ovarian cancer

Advances in experimental medicine and biology, 2008, Vol.622, p.197

2008

Volltextzugriff (PDF)

Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium

Advances in experimental medicine and biology, 2008, Vol.622, p.53

2008

Volltextzugriff (PDF)

Epigenetic markers of ovarian cancer

Advances in experimental medicine and biology, 2008, Vol.622, p.35

2008

Volltextzugriff (PDF)

Role of vascular leukocytes in ovarian cancer neovascularization

Advances in experimental medicine and biology, 2008, Vol.622, p.273

2008

Volltextzugriff (PDF)

Ovulatory factor in ovarian carcinogenesis

Advances in experimental medicine and biology, 2008, Vol.622, p.119

Murdoch, William J

2008

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(134)
Science & Technology
(109)
Life Sciences & Biomedicine
(93)
Female
(89)
Animals
(71)
Male
(61)
Middle Aged
(38)
Adult
(35)
Medicine, Research & Experimental
(35)
Research & Experimental Medicine
(35)
Ovarian Cancer
(30)
Drug Resistance
(29)
Rats
(29)
Respiratory System
(27)
Neoplasms - Drug Therapy
(26)
Aged
(24)
Antineoplastic Agents - Pharmacology
(21)
Copd
(17)
Multidrug Resistance
(16)
Antineoplastic Agents - Therapeutic Use
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]

Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD

P813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB

Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies

Environmental aspects of the carcinogenic situation in developed industrial region

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other

Role of p53 and Rb in ovarian cancer

CORRIGENDUM

Ovarian carcinogenesis: an alternative hypothesis

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Patient Device Satisfaction With Eflow Closed System Nebulizer: Results From The Golden-5 Study In Patients With Moderate-To Very-Severe Chronic Obstructive Pulmonary Disease (COPD)

A37 THE SPECTRUM OF COPD: EPIDEMIOLOGY TO OUTCOMES: Health-Related Quality Of Life (hrqol) In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Sun-101 (glycopyrrolate/eflow®): Findings From The Phase 3 Golden Studies

C49 COPD: TREATMENT: Improvement In Respiratory Symptoms In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease Patients Treated With Sun-101 (glycopyrrolate/eflow®) - Patient-Reported Outcomes From The Phase 3 Golden Studies

Regulatory T cells: a new frontier in cancer immunotherapy

Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax

Potential and limitations in early diagnosis of ovarian cancer

Defective apoptosis underlies chemoresistance in ovarian cancer

Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium

Epigenetic markers of ovarian cancer

Role of vascular leukocytes in ovarian cancer neovascularization

Ovulatory factor in ovarian carcinogenesis

Suchergebnisse filtern